Xarlyn Pulido Rantung, NPC

Xarlyn Rantung practices at Contour Dermatology And Cosmetic Surgery Center in Rancho Mirage, California.

Xarlyn Rantung's NPI, 1952829228, was assigned on September 6, 2017. Xarlyn Rantung holds California license 95002649.

Xarlyn Rantung's primary practice is Contour Dermatology and Cosmetic Surgery Center, at 42600 Mirage Rd Suite A1 Suite A1, Rancho Mirage, CA 92270-4127. The practice phone is (760) 423-4000.

Xarlyn Rantung's primary practice is Contour Dermatology And Cosmetic Surgery Center in Rancho Mirage, California. Xarlyn Rantung is also affiliated with Eisenhower Health. The medical group on file is Contour Dermatology and Cosmetic Surgery Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Xarlyn Rantung practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Xarlyn Rantung's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Xarlyn Rantung is licensed in California.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, scalp rash, skin cyst and skin discoloration among the conditions Xarlyn Rantung treats.

CMS data shows 4,410 Medicare services from Xarlyn Rantung across 18 procedure codes in 2024, for 749 Medicare patients. Medicare paid $223,367 for them. Every service was in an office.

CMS counts 749 Medicare patients who saw Xarlyn Rantung in 2024. The largest group is 65 to 74, with 363 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Xarlyn Rantung's median patient age at 69, with 44% women.

In 2024, Xarlyn Rantung wrote 512 Medicare Part D claims for 265 patients. 97% of them were for generic drugs. CMS names the drug for 425 of them, across 9 drugs with 11 or more claims each, at $9,120 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Xarlyn Rantung for performance year 2024, reported as part of a group. Xarlyn Rantung accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 19 general payments to Xarlyn Rantung from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 81% of the total. Abbvie Inc. paid the most, $168.